Enanta Pharmaceuticals Inc (ENTA)
$10.71 -3.95% Close Oct 30, 2026 Live
Enanta Pharmaceuticals stock today
Enanta Pharmaceuticals closed at $10.71 on October 30, 2026, down 3.95% on the day. Over the past year it returned -1.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $311 million.
$12.00$14.00$16.00
NovJan 2026MarMayJulSep
| Period | ENTA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -18.7% | -0.9% |
| 3 months | -17.6% | +2.1% |
| Year to date | -32.1% | +11.7% |
| 1 year | -1.4% | +12.4% |
| 3 years | +21.4% | +88.5% |
| 5 years | -87.5% | +76.0% |
Key statistics
- Market value
- $311M
- Price / sales
- 4.8
- 52-week range
- $10.71 to $16.85
- Next report
- Nov 16, 2026 (estimated)
About Enanta Pharmaceuticals
Biopharmaceutical company developing antiviral therapies for hepatitis and other diseases.
Sector: Health Care
More on Enanta Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue -3% in the year to Sep 2025
- Valuation: P/E history and peers
- Returns: what $1,000 became$1,000 ten years ago is $447.56 today
No forecast, no recommendation. This page describes Enanta Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.